Search results
- 6.33Add to watchlist-0.34 (-5.10%)As of Fri. Jun 7, 2024 2:24 PM EDT · Nasdaq Real Time Price (USD) · Market open
- Open6.49High6.77Low6.33
- Mkt Cap70.72MP/E (TTM)N/ADiv & YieldN/A & N/A
- Prev. Close6.6752 Wk. Low4.7952 Wk. High22.49
Top storiesHalozyme (HALO) Raises 2024 Financial Guidance, Stock Up 13%Yahoo Finance · 5 hours ago- ANVS -5.10%
Wall Street Analysts Think Annovis Bio (ANVS) Could Surge 359.53%: Read This Before Placing a BetYahoo Finance · 1 week ago- ANVS -5.10%
Repare (RPTX) Up 14% as Ovarian Cancer Combo Gets Fast Track TagYahoo Finance · 1 day agoRelated stocks
Find the latest Annovis Bio, Inc. (ANVS) stock quote, history, news and other vital information to help you with your stock trading and investing.
Annovis Bio is a biotechnology company that develops drugs to treat Alzheimer's, Parkinson's and other neurodegenerative diseases. It targets neurotoxic proteins that impair axonal transport and cause nerve cell death.
1 day ago · Annovis Bio stock price target raised to $150 from $45 at Maxim Group. Jul. 7, 2021 at 8:30 a.m. ET by Tomi Kilgore.
2 days ago · MALVERN, Pa., June 05, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering ...
2 days ago · MALVERN, Pa., June 05, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis, Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer’s Disease (AD) and Parkinson’s Disease (PD), today announced that it will host an investor webcast to discuss recent developments and ...
Apr 29, 2024 · Out of 325 patients who completed the Phase II/III trial, 202 had a ratio of pTau217/tTau≥4.2% that indicates AD. We further subdivided the patient population into moderate (MMSE 14-20; 112 ...
People also ask
What is the ANVs?
What is an ANVSA?
What are ANVs guidelines?
What is anvs405 & anvs301?
2 days ago · ANVS is the ticker symbol for Annovis Bio Inc, a biotechnology company developing drugs for neurodegenerative diseases. See the latest stock price, news, ratings, valuation, and financials for ANVS on Morningstar.